Treatment of hypertriglyceridemia. NIH Consensus Development Conference summary.
D000818:Animals; D002994:Clofibrate / Q000627:therapeutic use; D005247:Feeding Behavior; D015248:Gemfibrozil; D006801:Humans; D006951:Hyperlipoproteinemias / Q000178:diet therapy / Q000188:drug therapy; D009316:National Institutes of Health (U.S.); D009525:Niacin / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D010421:Pentanoic Acids / Q000627:therapeutic use; D005082:Physical Exertion; D012907:Smoking; D014280:Triglycerides / Q000097:blood*; D014481:United States
D010421:Pentanoic Acids; D014280:Triglycerides; D009525:Niacin; D002994:Clofibrate; D015248:Gemfibrozil